Skip to content

PROPHARMA: what changed

BE 0645.717.815NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€84,153
2024 · €140,559-€56,406
Equity
€250,000
2024 · €369,885-€119,885
Cash
€195,358
2024 · €487,211-€291,853
Balance sheet total
€915,541
2024 · €1.1m-€187,195

Largest movements

2024 to 2025
Assets
  • Cash -€291,853

    down €291,853 (-59.9%), from €487,211 to €195,358

    mainly Contributions, distributions and other (-€204,039) and Investment in fixed assets (net) (-€93,961)

  • Tangible fixed assets +€38,587

    up €38,587 (+18.6%), from €207,327 to €245,914

    of which Furniture and vehicles: +€36,844

  • Receivables within one year +€35,964

    up €35,964 (+25.6%), from €140,271 to €176,235

    of which Other amounts receivable: +€22,472

  • Deferred charges and accrued income +€33,877

    up €33,877 (+350%), from €9,677 to €43,555

  • Stocks and contracts -€14,448

    down €14,448 (-7.8%), from €185,723 to €171,275

Equity and liabilities
  • Profit (loss) carried forward -€114,194

    no longer reported in 2025; in 2024 it stood at €114,194

  • Other debts -€92,587

    down €92,587 (-30.3%), from €305,612 to €213,025

  • Trade debts +€57,652

    up €57,652 (+25.7%), from €224,393 to €282,045

  • Tax, wage and social debts -€16,429

    down €16,429 (-37.8%), from €43,476 to €27,047

    of which Taxes: -€21,009

  • Debts after one year -€16,205

    down €16,205 (-11.3%), from €143,424 to €127,219

Income statement
  • Staff costs +€53,606

    up €53,606 (+27.8%), from €192,990 to €246,597

  • Taxes -€23,839

    down €23,839 (-51.8%), from €45,994 to €22,155

  • Gross operating margin -€18,172

    down €18,172 (-4.3%), from €424,169 to €405,998

  • Depreciation +€6,227

    up €6,227 (+16.2%), from €38,468 to €44,696

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €140,559
Gross operating margin -€18,172
Staff costs -€53,606
Depreciation -€6,227
Other operating charges -€1,743
Financial income -€849
Financial charges +€353
Taxes +€23,839
Result 2025 €84,153
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€22,091
Investment -€93,961
Financing -€219,983
Cash 2024 €487,211
Net result for the year +€84,153
Depreciation +€44,696
Stocks and contracts +€14,448
Receivables within one year -€35,964
Deferred charges and accrued income -€33,877
Trade debts +€57,652
Tax, wage and social debts -€16,429
Other debts -€92,587
Investment in fixed assets (net) -€93,961
Debts after one year -€16,205
Current portion of long-term debt +€261
Contributions, distributions and other -€204,039
Cash 2025 €195,358
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,102,736 €915,541 -€187,195 -17.0%
Fixed assets 21/28 €229,854 €279,119 +€49,265 +21.4%
Tangible fixed assets 22/27 €207,327 €245,914 +€38,587 +18.6%
Land and buildings 22 €179,336 €167,936 -€11,401 -6.4%
Plant, machinery and equipment 23 €2,105 €13,189 +€11,084 +527%
Furniture and vehicles 24 €3,694 €40,538 +€36,844 +997%
Other tangible fixed assets 26 €22,192 €24,251 +€2,059 +9.3%
Financial fixed assets 28 €22,527 €33,205 +€10,678 +47.4%
Current assets 29/58 €872,882 €636,422 -€236,459 -27.1%
Stocks and contracts in progress 3 €185,723 €171,275 -€14,448 -7.8%
Stocks 30/36 €185,723 €171,275 -€14,448 -7.8%
Amounts receivable within one year 40/41 €140,271 €176,235 +€35,964 +25.6%
Trade receivables 40 €123,841 €137,333 +€13,492 +10.9%
Other amounts receivable 41 €16,430 €38,902 +€22,472 +137%
Current investments 50/53 €50,000 €50,000 = 0.0%
Cash at bank and in hand 54/58 €487,211 €195,358 -€291,853 -59.9%
Deferred charges and accrued income 490/1 €9,677 €43,555 +€33,877 +350%
Total equity and liabilities 10/49 €1,102,736 €915,541 -€187,195 -17.0%
Equity 10/15 €369,885 €250,000 -€119,885 -32.4%
Contributions 10/11 €200,000 €200,000 = 0.0%
Reserves 13 €55,691 €50,000 -€5,691 -10.2%
Non-distributable reserves 130/1 €50,000 €50,000 = 0.0%
Reserves not available under the articles 1311 €50,000 €50,000 = 0.0%
Distributable reserves 133 €5,691 - -€5,691
Profit (loss) carried forward 14 €114,194 - -€114,194
Amounts payable 17/49 €732,851 €665,541 -€67,309 -9.2%
Amounts payable after more than one year 17 €143,424 €127,219 -€16,205 -11.3%
Financial debts 170/4 €143,424 €127,219 -€16,205 -11.3%
Amounts payable within one year 42/48 €589,426 €538,322 -€51,104 -8.7%
Current portion of amounts payable after more than one year 42 €15,945 €16,205 +€261 +1.6%
Trade debts 44 €224,393 €282,045 +€57,652 +25.7%
Suppliers 440/4 €224,393 €282,045 +€57,652 +25.7%
Taxes, remuneration and social security 45 €43,476 €27,047 -€16,429 -37.8%
Taxes 450/3 €21,009 - -€21,009
Remuneration and social security 454/9 €22,467 €27,047 +€4,580 +20.4%
Other amounts payable 47/48 €305,612 €213,025 -€92,587 -30.3%
Remuneration, social security and pensions 62 €192,990 €246,597 +€53,606 +27.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €38,468 €44,696 +€6,227 +16.2%
Other operating charges 640/8 €2,430 €4,173 +€1,743 +71.7%
Gross operating margin 9900 €424,169 €405,998 -€18,172 -4.3%
Operating profit (loss) 9901 €190,281 €110,532 -€79,748 -41.9%
Financial income 75/76B €1,484 €634 -€849 -57.2%
Recurring financial income 75 €1,484 €634 -€849 -57.2%
Financial charges 65/66B €5,211 €4,858 -€353 -6.8%
Recurring financial charges 65 €5,211 €4,858 -€353 -6.8%
Profit (loss) for the period before taxes 9903 €186,553 €106,309 -€80,245 -43.0%
Income taxes 67/77 €45,994 €22,155 -€23,839 -51.8%
Profit (loss) for the period 9904 €140,559 €84,153 -€56,406 -40.1%
Profit (loss) for the period to be appropriated 9905 €140,559 €84,153 -€56,406 -40.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€564,093 to €739,730

Midpoint €637,275 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €250,000
Capitalised earnings €878,186 to €1.2m
Indication €564,093 to €739,730

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€250,000
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€250,000

Capitalised earnings

net result for the year (9904)
2025
€84,153
2024
€140,559
2023
€144,124
2022
€79,975
2021
€94,595
Average result
€122,946
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€878,186 / €1.0m / €1.2m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.